{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:57:09Z","timestamp":1790121429608,"version":"4.0.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T00:00:00Z","timestamp":1643414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T00:00:00Z","timestamp":1643414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81302565"],"award-info":[{"award-number":["81302565"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Xiamen Medical and Health Project","award":["3502Z20189009"],"award-info":[{"award-number":["3502Z20189009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s10067-021-06036-4","type":"journal-article","created":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T00:02:43Z","timestamp":1643414563000},"page":"1465-1472","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Abnormal Histones Acetylation in Patients with Primary Sj\u00f6gren's Syndrome"],"prefix":"10.1007","volume":"41","author":[{"given":"Xiuying","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxiu","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guixiu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5587-2784","authenticated-orcid":false,"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,29]]},"reference":[{"key":"6036_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/03009740310004676","volume":"33","author":"SJ Bowman","year":"2004","unstructured":"Bowman SJ, Ibrahim GH, Holmes G, Hamburger J et al (2004) Estimating the prevalence among Caucasian women of primary Sjogren\u2019s syndrome in two general practices in Birmingham, UK. Scand J Rheumatol 33:39\u201343","journal-title":"Scand J Rheumatol"},{"key":"6036_CR2","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1136\/annrheumdis-2014-205375","volume":"74","author":"B Qin","year":"2015","unstructured":"Qin B, Wang J, Yang Z, Yang M et al (2015) Epidemiology of primary Sjogren\u2019s syndrome: a systematic review and meta-analysis. Ann Rheum Dis 74:1983\u20131989. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205375","journal-title":"Ann Rheum Dis"},{"key":"6036_CR3","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1002\/art.27611","volume":"62","author":"GJ Tobon","year":"2010","unstructured":"Tobon GJ, Renaudineau Y, Hillion S, Cornec D et al (2010) The Fms-like tyrosine kinase 3 ligand, a mediator of B cell survival, is also a marker of lymphoma in primary Sjogren\u2019s syndrome. Arthritis Rheum 62:3447\u20133456. https:\/\/doi.org\/10.1002\/art.27611","journal-title":"Arthritis Rheum"},{"key":"6036_CR4","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1093\/rheumatology\/kex157","volume":"56","author":"RC Manuel","year":"2017","unstructured":"Manuel RC, Pilar BZ, Raphaele S, Hendrika B et al (2017) Characterization of systemic disease in primary Sjogren\u2019s syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements. Rheumatology (Oxford) 56:1245. https:\/\/doi.org\/10.1093\/rheumatology\/kex157","journal-title":"Rheumatology (Oxford)"},{"key":"6036_CR5","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.2174\/138920112802273326","volume":"13","author":"C Le Dantec","year":"2012","unstructured":"Le Dantec C, Varin MM, Brooks WH, Pers JO et al (2012) Epigenetics and Sjogren\u2019s syndrome. Curr Pharm Biotechnol 13:2046\u20132053","journal-title":"Curr Pharm Biotechnol"},{"key":"6036_CR6","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/art.38264","volume":"66","author":"N Altorok","year":"2014","unstructured":"Altorok N, Coit P, Hughes T, Koelsch KA et al (2014) Genome-wide DNA methylation patterns in naive CD4+ T cells from patients with primary Sjogren\u2019s syndrome. Arthritis & rheumatology 66:731\u2013739. https:\/\/doi.org\/10.1002\/art.38264","journal-title":"Arthritis & rheumatology"},{"key":"6036_CR7","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1136\/annrheumdis-2015-208659","volume":"75","author":"J Imgenberg-Kreuz","year":"2016","unstructured":"Imgenberg-Kreuz J, Sandling JK, Almlof JC, Nordlund J et al (2016) Genome-wide DNA methylation analysis in multiple tissues in primary Sjogren\u2019s syndrome reveals regulatory effects at interferon-induced genes. Ann Rheum Dis 75:2029\u20132036. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208659","journal-title":"Ann Rheum Dis"},{"key":"6036_CR8","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jaut.2015.12.002","volume":"68","author":"OD Konsta","year":"2016","unstructured":"Konsta OD, Le Dantec C, Charras A, Cornec D et al (2016) Defective DNA methylation in salivary gland epithelial acini from patients with Sjogren\u2019s syndrome is associated with SSB gene expression, anti-SSB\/LA detection, and lymphocyte infiltration. J Autoimmun 68:30\u201338. https:\/\/doi.org\/10.1016\/j.jaut.2015.12.002","journal-title":"J Autoimmun"},{"key":"6036_CR9","first-page":"e01","volume":"53","author":"OD Konsta","year":"2016","unstructured":"Konsta OD, Charras A, Le Dantec C, Kapsogeorgeou E et al (2016) Epigenetic modifications in salivary glands from patients with Sjogren\u2019s syndrome affect cytokeratin 19 expression. Bull Group Int Rech Sci Stomatol Odontol 53:e01","journal-title":"Bull Group Int Rech Sci Stomatol Odontol"},{"key":"6036_CR10","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1002\/eji.201040757","volume":"41","author":"KM Pauley","year":"2011","unstructured":"Pauley KM, Stewart CM, Gauna AE, Dupre LC et al (2011) Altered miR-146a expression in Sjogren\u2019s syndrome and its functional role in innate immunity. Eur J Immunol 41:2029\u20132039. https:\/\/doi.org\/10.1002\/eji.201040757","journal-title":"Eur J Immunol"},{"key":"6036_CR11","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.3899\/jrheum.131154","volume":"41","author":"L Peng","year":"2014","unstructured":"Peng L, Ma W, Yi F, Yang YJ et al (2014) MicroRNA profiling in Chinese patients with primary Sjogren syndrome reveals elevated miRNA-181a in peripheral blood mononuclear cells. J Rheumatol 41:2208\u20132213. https:\/\/doi.org\/10.3899\/jrheum.131154","journal-title":"J Rheumatol"},{"key":"6036_CR12","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1111\/jop.12187","volume":"43","author":"H Shi","year":"2014","unstructured":"Shi H, Zheng LY, Zhang P, Yu CQ (2014) miR-146a and miR-155 expression in PBMCs from patients with Sjogren\u2019s syndrome. J Oral Pathol Med 43:792\u2013797. https:\/\/doi.org\/10.1111\/jop.12187","journal-title":"J Oral Pathol Med"},{"key":"6036_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13075-016-0987-0","volume":"18","author":"AE Williams","year":"2016","unstructured":"Williams AE, Choi K, Chan AL, Lee YJ et al (2016) Sjogren\u2019s syndrome-associated microRNAs in CD14(+) monocytes unveils targeted TGFbeta signaling. Arthritis Res Ther 18:95. https:\/\/doi.org\/10.1186\/s13075-016-0987-0","journal-title":"Arthritis Res Ther"},{"key":"6036_CR14","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s10067-016-3203-3","volume":"35","author":"Y Yang","year":"2016","unstructured":"Yang Y, Peng L, Ma W, Yi F et al (2016) Autoantigen-targeting microRNAs in Sjogren\u2019s syndrome. Clin Rheumatol 35:911\u2013917. https:\/\/doi.org\/10.1007\/s10067-016-3203-3","journal-title":"Clin Rheumatol"},{"key":"6036_CR15","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1111\/j.1582-4934.2011.01456.x","volume":"16","author":"Y Yamamura","year":"2012","unstructured":"Yamamura Y, Motegi K, Kani K, Takano H et al (2012) TNF-alpha inhibits aquaporin 5 expression in human salivary gland acinar cells via suppression of histone H4 acetylation. J Cell Mol Med 16:1766\u20131775. https:\/\/doi.org\/10.1111\/j.1582-4934.2011.01456.x","journal-title":"J Cell Mol Med"},{"key":"6036_CR16","doi-asserted-by":"publisher","first-page":"9287","DOI":"10.1074\/jbc.M512956200","volume":"281","author":"LJ Benson","year":"2006","unstructured":"Benson LJ, Gu Y, Yakovleva T, Tong K et al (2006) Modifications of H3 and H4 during chromatin replication, nucleosome assembly, and histone exchange. J Biol Chem 281:9287\u20139296. https:\/\/doi.org\/10.1074\/jbc.M512956200","journal-title":"J Biol Chem"},{"key":"6036_CR17","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/sj.leu.2404478","volume":"21","author":"TC Karagiannis","year":"2007","unstructured":"Karagiannis TC, El-Osta A (2007) Chromatin modifications and DNA double-strand breaks: the current state of play. Leukemia 21:195\u2013200. https:\/\/doi.org\/10.1038\/sj.leu.2404478","journal-title":"Leukemia"},{"key":"6036_CR18","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0167-4889(01)00141-0","volume":"1541","author":"LW Yuan","year":"2001","unstructured":"Yuan LW, Gambee JE (2001) Histone acetylation by p300 is involved in CREB-mediated transcription on chromatin. Biochim Biophys Acta 1541:161\u2013169","journal-title":"Biochim Biophys Acta"},{"key":"6036_CR19","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1515\/BC.2008.048","volume":"389","author":"KA Gelato","year":"2008","unstructured":"Gelato KA, Fischle W (2008) Role of histone modifications in defining chromatin structure and function. Biol Chem 389:353\u2013363. https:\/\/doi.org\/10.1515\/BC.2008.048","journal-title":"Biol Chem"},{"key":"6036_CR20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/nrrheum.2016.208","volume":"13","author":"A Vissink","year":"2016","unstructured":"Vissink A, Bootsma H (2016) Connective tissue diseases: Refining the classification criteria for primary Sjogren syndrome. Nat Rev Rheumatol 13:10\u201312. https:\/\/doi.org\/10.1038\/nrrheum.2016.208","journal-title":"Nat Rev Rheumatol"},{"key":"6036_CR21","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1471-2164-7-90","volume":"7","author":"H Ozdag","year":"2006","unstructured":"Ozdag H, Teschendorff AE, Ahmed AA, Hyland SJ et al (2006) Differential expression of selected histone modifier genes in human solid cancers. BMC Genomics 7:90. https:\/\/doi.org\/10.1186\/1471-2164-7-90","journal-title":"BMC Genomics"},{"key":"6036_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070939","volume":"8","author":"E Toussirot","year":"2013","unstructured":"Toussirot E, Abbas W, Khan KA, Tissot M et al (2013) Imbalance between HAT and HDAC activities in the PBMCs of patients with ankylosing spondylitis or rheumatoid arthritis and influence of HDAC inhibitors on TNF alpha production. PLoS ONE 8:e70939. https:\/\/doi.org\/10.1371\/journal.pone.0070939","journal-title":"PLoS ONE"},{"key":"6036_CR23","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/art.33382","volume":"64","author":"J Gillespie","year":"2012","unstructured":"Gillespie J, Savic S, Wong C, Hempshall A et al (2012) Histone deacetylases are dysregulated in rheumatoid arthritis and a novel histone deacetylase 3-selective inhibitor reduces interleukin-6 production by peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Rheum 64:418\u2013422. https:\/\/doi.org\/10.1002\/art.33382","journal-title":"Arthritis Rheum"},{"key":"6036_CR24","first-page":"804","volume":"35","author":"N Hu","year":"2008","unstructured":"Hu N, Qiu X, Luo Y, Yuan J et al (2008) Abnormal histone modification patterns in lupus CD4+ T cells. J Rheumatol 35:804\u2013810","journal-title":"J Rheumatol"},{"key":"6036_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1021\/acs.jproteome.7b00270","volume":"17","author":"R Lillico","year":"2018","unstructured":"Lillico R, Zhou T, Khorshid Ahmad T, Stesco N et al (2018) Increased Post-Translational Lysine Acetylation of Myelin Basic Protein Is Associated with Peak Neurological Disability in a Mouse Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis. J Proteome Res 17:55\u201362. https:\/\/doi.org\/10.1021\/acs.jproteome.7b00270","journal-title":"J Proteome Res"},{"key":"6036_CR26","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1021\/pr050188r","volume":"4","author":"BA Garcia","year":"2005","unstructured":"Garcia BA, Busby SA, Shabanowitz J, Hunt DF et al (2005) Resetting the epigenetic histone code in the MRL-lpr\/lpr mouse model of lupus by histone deacetylase inhibition. J Proteome Res 4:2032\u20132042. https:\/\/doi.org\/10.1021\/pr050188r","journal-title":"J Proteome Res"},{"key":"6036_CR27","first-page":"490","volume":"52","author":"S Miyagi","year":"2011","unstructured":"Miyagi S, Mishima Y, Iwama A (2011) Structure and function of MYST family histone acetyltransferases. Rinsho Ketsueki 52:490\u2013496","journal-title":"Rinsho Ketsueki"},{"key":"6036_CR28","doi-asserted-by":"publisher","first-page":"657","DOI":"10.14670\/HH-17.657","volume":"17","author":"R Janknecht","year":"2002","unstructured":"Janknecht R (2002) The versatile functions of the transcriptional coactivators p300 and CBP and their roles in disease. Histol Histopathol 17:657\u2013668. https:\/\/doi.org\/10.14670\/HH-17.657","journal-title":"Histol Histopathol"},{"key":"6036_CR29","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.bcp.2004.03.045","volume":"68","author":"E Kalkhoven","year":"2004","unstructured":"Kalkhoven E (2004) CBP and p300: HATs for different occasions. Biochem Pharmacol 68:1145\u20131155. https:\/\/doi.org\/10.1016\/j.bcp.2004.03.045","journal-title":"Biochem Pharmacol"},{"key":"6036_CR30","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0092-8674(00)80516-4","volume":"90","author":"H Chen","year":"1997","unstructured":"Chen H, Lin RJ, Schiltz RL, Chakravarti D et al (1997) Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P\/CAF and CBP\/p300. Cell 90:569\u2013580","journal-title":"Cell"},{"key":"6036_CR31","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1182\/blood.V96.4.1490","volume":"96","author":"Y Koyama","year":"2000","unstructured":"Koyama Y, Adachi M, Sekiya M, Takekawa M et al (2000) Histone deacetylase inhibitors suppress IL-2-mediated gene expression prior to induction of apoptosis. Blood 96:1490\u20131495","journal-title":"Blood"},{"key":"6036_CR32","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.intimp.2007.05.022","volume":"7","author":"H Matsuoka","year":"2007","unstructured":"Matsuoka H, Fujimura T, Mori H, Aramori I et al (2007) Mechanism of HDAC inhibitor FR235222-mediated IL-2 transcriptional repression in Jurkat cells. Int Immunopharmacol 7:1422\u20131432. https:\/\/doi.org\/10.1016\/j.intimp.2007.05.022","journal-title":"Int Immunopharmacol"},{"key":"6036_CR33","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.actbio.2018.03.002","volume":"71","author":"ML Ratay","year":"2018","unstructured":"Ratay ML, Balmert SC, Bassin EJ, Little SR (2018) Controlled release of an HDAC inhibitor for reduction of inflammation in dry eye disease. Acta Biomater 71:261\u2013270. https:\/\/doi.org\/10.1016\/j.actbio.2018.03.002","journal-title":"Acta Biomater"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-06036-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-021-06036-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-06036-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T11:04:05Z","timestamp":1651316645000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-021-06036-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,29]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["6036"],"URL":"https:\/\/doi.org\/10.1007\/s10067-021-06036-4","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,29]]},"assertion":[{"value":"7 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patient consent was obtained. This study was approved by the Ethics Committee of the First Affiliated Hospital of Xiamen University in accordance with the World Medical Association Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}